Background: Today, no specific test for the diagnosis of multiple sclerosis (MS) is available due to the lack of characteristic symptoms at beginning. This circumstance also complicates estimation of disease progression. Recent findings provided evidence for early, non-lesional cerebellar damage in patients with (clinically definite) relapsingremitting MS.
Introduction
Relapsing-remitting multiple sclerosis (MS) occurs with a variety of different symptoms such as vision problems, changes in sensation, and muscle weakness (Miller et al., 2005b; Sospedra and Martin, 2005) . These unspecific symptoms alone do not permit the diagnosis of MS. For diagnosis of MS according to the current McDonald criteria (Polman et al., 2011) magnetic resonance imaging (MRI) detectable lesions in the central nervous system are mandatory. Patients with clinical signs alone without dissemination of lesions in space and time are classified as clinically isolated syndrome (CIS) -a potential subacute phase of MS onset (Miller et al., 2005b) .
The conceptual delimitation between CIS and MS is however problematic because patients with CIS frequently already demonstrate abnormalities in normal appearing white and grey matter indicating an advanced pathological state (Miller et al., 2005a) . A relevant number of patients with CIS (30-70 %) develop MS, where silent MRI lesions increase the likelihood (Miller et al., 2005b) . Current McDonald criteria (Polman et al., 2011) and MAGNIMS revisions (Filippi et al., 2016; Montalban et al., 2010; Rovira et al., 2009; Swanton et al., 2006) focus on the relevance of MRI criteria, such as dissemination in space and time. Especially in context with the term dissemination in time, it seems interesting to consider lesion-preceding processes. Recent studies provided evidence that microstructural tissue alterations in normal appearing white matter (NAWM), in the following briefly microstructural tissue alterations, can precede macroscopic lesions and white matter (WM) tissue atrophy in patients with MS (Deppe et al., 2014; Deppe et al., 2016a) . The major problem with tissue alterations on a micron level is that conventional MRI can fail to detect them (Deppe et al., 2013) . Instead, microstructure-sensitive MRI protocols like diffusion tensor imaging (DTI) are necessary. The most prominent DTI A C C E P T E D M A N U S C R I P T measure for quantitative assessment of microstructural alterations of NAWM based on normal values is the fractional anisotropy (FA) (Deppe et al., 2007) .
The majority of recent studies on patients with MS investigated cerebral white matter, although infratentorial white matter is also affected. In the present study, we exclusively focused on cerebellar changes because infratentorial tissue alterations are of special interest due to their higher prevalence in MS compared to other inflammatory diseases (Tobyne et al., 2017) and their prognostic relevance for disability progression (Minneboo et al., 2004; Rovira et al., 2009; Wattjes et al., 2007) . MS differential diagnoses like neuromyelitis optica (NMO) (Fan et al., 2017) , arterial hypertension, cerebral autosomal dominant arteriopathy and Susac syndrome (Kleffner et al., 2008; Kleffner et al., 2010; Kleffner et al., 2012) show MS-like symptoms, but less cerebellar involvement.
Recently it was demonstrated by means of DTI that "normal appearing" cerebellar white matter could be damaged on a microscopic level in a very early stage of MS without presenting macroscopic lesions in T1w or T2w MRI (Deppe et al., 2016a; Deppe et al., 2016b) . Interestingly, this non-lesional microstructural damage preceded cerebellar atrophy (Deppe et al., 2016b) . Against this background, we hypothesized that (1) patients with CIS have already decreased cerebellar WM FA (used interchangeably: cerebellar FA).
(2) The amount of decreased initial cerebellar FA has a predictive value for disease progression, namely the time to convert into (clinically definitive) MS. We further speculated that microstructural disease activity as assessed by further FA reduction at a follow-up MRI might be associated with (3) cerebellar atrophy and (4) the patients' expanded disability status scale (EDSS) -indicating an advanced disease stage and ongoing disease activity.
A C C E P T E D M A N U S C R I P T

Methods
Subjects
Forty-six consecutive patients (31 f, 15 m) with a CIS and without evidence for cerebellar lesions were included in our study for high-resolution structural and diffusion weighted MRI at 3T (EDSS: range 0 to 3. (Deppe et al., 2016b) .
Written informed consent was obtained from all study participants. The participants were also informed that the examination could reveal potentially medically significant findings and given the option to request notification in the event of such findings. The interdisciplinary committee of the University of Münster and the Westphalia-Lippe
Chamber of Physicians (Ärztekammer Westfalen-Lippe) approved all examinations (ref.
2010-378-b-S).
MRI
All participants were scanned using a 3T Siemens MRI scanner and a 64-channel head/neck coil (Siemens AG, Erlangen, Germany) using the same MRI parameters and protocols: 3D T1w MP-RAGE (192 sagittal slices, FOV 256 mm, 1 mm isotropic resolution, GRAPPA 2) for cerebellum reconstruction and a diffusion weighted EPI protocol (36 axial slices, FOV 230 mm, slice thickness 3.6 mm, resolution 1.8 mm x 1.8 mm, 20 gradient directions with b=1000 s/mm 2 , 5 x b=0 s/mm 2 , GRAPPA 2) for DTI.
Scan time for the DTI protocol was 3.5 min. In addition, a FLAIR protocol for lesion assessment was applied (192 sagittal slices, FOV 256 mm, 1mm isotropic resolution). A 3D MP-RAGE T1-weighted after intravenous gadolinium-DTPA (diethylene triamine penta-acetic acid) 0.1 mmol/kg injection was applied only for the patients with CIS. For further details see (Deppe et al., 2016b ). An experienced radiologist inspected all FLAIR images for potential macroscopic lesions. Only patients without any structural abnormalities were included in our study. In the subgroup of the 16 converted patients
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the conventional MRI protocol (T1w, T1w+Gd-DTPA, FLAIR) built the basis for the diagnosis of (clinically definite) MS.
DTI data post-processing DTI data preprocessing including eddy current and movement correction, rigorous spatial registration, and smoothing has been described elsewhere (Deppe et al., 2016a; Mohammadi et al., 2010) . The registration algorithm provided rigorous iterative multicontrast registration steps based on FA contrasts and b0 contrasts (b = 0 s/mm 2 ), so that volumetric effects in the resulting normalized FA maps were negligible (Mohammadi et al., 2012) . All registered diffusivity images corresponded to the MNI (Montreal Neurologic Institute) coordinate space. Smoothing of these images was performed by employing position-orientation adaptive smoothing (POAS) (Becker et al., 2012; Becker et al., 2014) using the ACID-toolbox (http://www.diffusiontools.org,) for SPM (http://www.fil.ion.ucl.ac.uk/spm/). POAS was parameterized by the following values: k* = 12, κ0 = 0.8,λ = 10, σ = 8, Ncoils = 1. A detailed explanation is given elsewhere (Becker et al., 2012; Becker et al., 2014) . The cerebral and cerebellar ROIs were generated from spatially registered and averaged FA maps. Further details about image processing are given elsewhere (Deppe et al., 2016b) .
Estimation of lesion load, cerebral, cerebellar and fourth ventricle volume
Prior to the automated analysis by FreeSurfer all 3D MPRAGE images were intensity inhomogeneity corrected to reduce segmentation errors using in-house software (EVAL 3.0). Volume of the cerebellum (CBWMV), intra-cranial volume (ICV) and white matter lesion load (WMLL) were obtained from FreeSurfer (Version 5.1;
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http://surfer.nmr.mgh.harvard.edu/) in the same way as described elsewhere (Deppe et al., 2016b) . The amount of automatically detected hypointensities in the T1w images in units of mm 3 served as a measure for WMLL. WM hyperintense lesions in T2w/FLAIR images were not considered because (i) we included only patients with no apparent T2w/FLAIR lesions and (ii) the main focus of the present study was the cerebellum.
From the CBWMV (unit: mm 3 ) and the absolute ICV (unit: mm 3 ) we calculated the relative (percentage) cerebellar WM volume as CBWMV / ICV x 100 %.
Statistical analysis
Testing our hypotheses, we employed general linear models (GLM, Statistica 10, Stat
Soft. Inc, www.statsoft.com) for cerebellar FA and fourth ventricular volume against the time between first and second examination. All differences in EDSS, cerebellar FA, and cerebellar volume had been linearly adjusted to a time interval between first and second examination of six months. Conversion latency had been determined and compared to cerebellar FA as determined in the first examination. WM volumes, cerebellar FA reduction, and cerebellar atrophy of CIS patients were compared between first and second examination and between healthy controls using paired t-tests. We divided our cohort into a group with short conversion latency (< 730 days = 24 months) and in a second group of patients presenting long conversion latency (730 -1600 days).
Results
Initial cerebellar FA correlates with conversion latency to MS
Our CIS cohort showed already at the first MRI a reduced mean cerebellar FA compared to healthy controls. The mean cerebellar FA in our present CIS collective (N=46, mean FA=0.336, SD=0.024) corresponded well to the mean FA in the early MS cohort of our 
Relative cerebellar WM volume
Consistent with our previous study (Deppe et al., 2016b) , neither relative nor absolute cerebellar white matter volumes were significantly reduced in patients with CIS relative
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to the HC group. No significant cerebellar white or grey matter volume change within the six months interval was observed. 
Cerebellar FA change between baseline and follow-up
Cerebellar FA reproducibility
Beside the systematic FA decrease, we found a good over-all reproducibility between the baseline and six months follow-up cerebellar FA values in the patients with CIS (diagnosis of CIS also at follow up), which differed typically less than +/-3 % (Figure 4 ).
Higher FA reductions reflected relatively high volumes of the fourth ventricle in relation
to the HC group. We observed a weak correlation (R=0.46, p=0.023) between initial fourth ventricular volume and the amount of cerebellar FA decrease between first and second examination.
A C C E P T E D M A N U S C R I P T EDSS and cerebellar white matter change
A correlation between initial EDSS and cerebellar white matter change during the 6 months follow-up interval was found (N=24, R=0.50, p=0.012). In none of the patients a relevant exacerbation of clinical symptoms (EDSS increase > 1 unit) was observed.
No evidence for macroscopic MRI alterations
The average volume of WM hypointensities (WMLL) did not differ between first and second examination (t=0.89, p=0.38) and also not between patients that converted and not converted from CIS to MS within the observation interval (t=0.30, p=0.77). All estimated volumes did not significantly differ from the healthy control cohort.
Discussion
Demyelination and neuroinflammation are of central interest in many disorders of the nervous system. However, MRI frequently fails to detect early active demyelination processes prior to lesion occurrence, as observed in a number of imaging studies involving diffusion weighted imaging (Deppe et al., 2016b) . Recent studies, see introduction, underlined the importance of cerebellar changes in early MS stages to differentiate between MS and other neuroinflammatory diseases, because the latter show typically less cerebellar involvement. Here we demonstrate significantly reduced cerebellar FA in patients with an early CIS who showed no indication for cerebellar degeneration by visually inspecting conventional MRIs. In our cohort, an initial FA under FAcrit=0.352 predicted a conversion into (clinically definite) relapsing-remitting MS within the next two years (Hypothesis 1, Figure 1) with reasonable sensitivity and specificity (ref. Table 1 ). Our objective was not to derive the critical FA value (FAcrit) by the present data, but to employ an a priori threshold representative for relapsing-
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remitting MS. Thus, we used the mean cerebellar FA of patients with early RRMS (FARRMS =0.352) as determined in our previous study on cerebellar FA ( Figures 2 and 4) . All higher FA discrepancies reflected always FA reductions that in turn were mainly associated with other clinical signs (increased EDSS) or short conversion times.
Why did we restrict our presented results mainly to the cerebellum and did not discuss the cerebellar alterations in context of cerebral white matter FA? According to the considerations given in the introduction, the first reason was that this study was intended as direct follow-up and validation of our previous findings on patients with early MS, now with the focus on patients with even earlier (subclinical) MS. The second
reason was, that in a tentative analysis of cerebral FA, it turned out that different WM 
automatically mean that this subject will convert into MS in the next future (compare 77 % "over-all specificity" without neurological findings). All results shown in Figure 1 and Table 1 refer exclusively on patients with an actually beginning MS that was only transiently diagnosed as CIS at the time of DTI.
Our study design and our results did also not permit to predict a "stable CIS course", i.e. no conversion into MS over a (life-) long period, because we compared only patients (N=16) that actually converted into MS during our study according to their individual conversion latencies. To target the question about predicting stable CIS courses, further research would be necessary that employs DTI for long-term observations to compare actual (long-term/lifelong) "non-converters" with "converters".
Given that the pathological processes exacerbate by time, we linearly adjusted the temporal FA change between MRI check-ups to a 6 months interval in order to account for different observation intervals. We further could exclude any confounding effects by age on the 6-months FA change (Figure 3 ). It has previously been difficult to validate directly the connection between FA, microstructural alterations, and exacerbation of clinical symptoms due to a lack of alternative (in vivo) gold standard methods providing similar data in humans, as well as the relative paucity of animal imaging data. In addition, it should be noted that neither our study nor any others of which we are aware have produced insights into how inflammation related biochemical processes, demyelination, and MRI measures actually interrelate. However, the found 6 months FA changes might most likely reflect functionally relevant alterations of the nervous system, because we found a relation between patients' EDSS and 6 months cerebellar FA reduction ( Figure 5 ).
The importance of fourth ventricular enlargement as one of the earliest MRI predictors for MS disease progression has been observed in a number of imaging studies (Lukas et al., 2010; Schneider et al., 2017) . The abnormalities of fourth ventricular volume exclusively appeared in patients with MS prior to symptom occurrence and lesion visibility in T2 MRI (Lepore et al., 2013) compared to healthy controls (Schneider et al., 2017) . These findings inspired our third hypothesis that disease activity as assessed by FA change might correlate with cerebellar atrophy. This hypothesis was supported by a correlation between cerebellar FA and fourth ventricular volume (Figure 4) 
